Identification
A:
Infrared Absorption á197Kñ.
B:
The retention time of the major peak in the chromatogram of the Assay preparationcorresponds to that in the chromatogram of the Standard preparation,as obtained in the Assay.
Chromatographic purity
Mobile phase
Proceed as directed in the Assay.
Standard stock solution
Prepare as directed for Standard preparationin the Assay.
Standard solution
Transfer 0.5mLof the Standard stock solutionto a 50-mLvolumetric flask,dilute with Mobile phaseto volume,and mix.
Test solution
Prepare as directed for Assay preparation.
Chromatographic system (see Chromatography á621ñ)
Prepare as directed in the
Assay.Chromatograph the
Standard stock solution,and record the peak responses as directed for
Procedure:the column efficiency is not less than 6000theoretical plates;and the relative standard deviation for replicate injections is not more than 2.0%.Chromatograph the
Test solution,and record the peak responses as directed for
Procedure:the resolution,
R,between dinoprostone and any other adjacent peak is not less than 1.0.
Procedure
Separately inject equal volumes (about 20µL)of the
Standard solutionand the
Test solutioninto the chromatograph,record the chromatograms,and measure the peak responses.Calculate the percentage of each impurity in the portion of Dinoprostone taken by the formula:
(C/W)(1/F)(ri/rS),
in which
Cis the concentration,in µg per mL,of
USP Dinoprostone RSin the
Standard solution;Wis the weight,in mg,of Dinoprostone taken to prepare the
Test solution;Fis the relative response factor (see
Table 1for values);
riis the peak response for each impurity obtained from the
Test solution;and
rSis the peak response for dinoprostone obtained from the
Standard solution.
Table 1.
| Impurity |
Relative Retention Time |
F |
Limit |
| 15-oxo-dinoprost-one |
0.79 |
5 |
* |
| 15-epi-dinoprostone |
0.85 |
1.1 |
* |
| 8-isodinoprostone |
0.90 |
1.0 |
* |
| 5,6-trans-dinoprost-one |
1.15 |
1.0 |
Not more than 2.0% |
| (5Z,13E,15S)-15-hy-droxy-9-oxopro-sta-5,10,13-tri-ene-1-oic acid |
1.80 |
5 |
Not more than 1.0% |
(5Z,13E,15S)-15-hydroxy-9-oxo-prosta-5,8(12), 13-trien-1-oic acid |
1.90 |
1.43 |
Not more than 1.0% |
| Any other impurity |
|
1.0 |
Not more than 0.1%of total other impurities present |
|
*
The sum of these three impurities is not more than 1.0%.
|
Assay
Mobile phase
Prepare a filtered and degassed mixture of methanol and 0.2%acetic acid (58:42).Make adjustments if necessary (see
System Suitabilityunder
Chromatography á621ñ).
Standard preparation
Dissolve an accurately weighed quantity of
USP Dinoprostone RSin
Mobile phase,and dilute quantitatively,and stepwise if necessary,with
Mobile phaseto obtain a solution having a known concentration of about 2.5mg per mL.
Assay preparation
Transfer about 25.0mg of Dinoprostone,accurately weighed,to a 10-mLvolumetric flask,dissolve in and dilute with Mobile phaseto volume,and mix.
Chromatographic system (see Chromatography á621ñ)
The liquid chromatograph is equipped with a 210-nm detector and a 4.6-mm ×25-cm column that contains packing L1.The flow rate is about 1mLper minute.The column temperature is maintained at 30

.Chromatograph the
Standard preparation,and record the peak responses as directed for
Procedure:the resolution,
R,between dinoprostone and any other adjacent peak is not less than 1.0;and the relative standard deviation for replicate injections is not more than 2.0%.
Procedure
Separately inject equal volumes (about 20µL)of the
Standard preparationand the
Assay preparationinto the chromatograph,record the chromatograms,and measure the responses for the major peaks.Calculate the quantity,in mg,of C
20H
32O
5in the portion of Dinoprostone taken by the formula:
10C(rU/rS),
in which
Cis the concentration,in mg per mL,of
USP Dinoprostone RSin the
Standard preparation;and
rUand
rSare the peak responses obtained from the
Assay preparationand the
Standard preparation,respectively.